Related Experiment Video
Updated: Jan 4, 2026

Manufacture and Drug Delivery Applications of Silk Nanoparticles
Published on: October 8, 2016
Nanoparticles-based drug delivery and gene therapy for breast cancer: Recent advancements and future challenges
1King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia; Department of Medical Lab Technology, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, Saudi Arabia.
Abstract:
Breast cancer (BC) is amongst the most lethal cancer among females and conventional treatment methods like surgery, radiotherapy and chemotherapy are not effective enough as expected and suffer concerns of low bioavailability, low cellular uptake, emerging resistance, and adverse toxicities. Gene therapy using free nucleic acids has potential to deal with key candidate genes of BC, but their effect is retarded due to poor cell uptake and instability in circulation. The rapidly evolving field of nanomedicine aiming targeted drug/gene delivery curtailing BC promises to overcome the limitations of conventional therapies. Nanoparticles can be game changer for BC gene therapy as they can be effective carrier of specific drug/gene by improving the circulation time, enhancing bioavailability, reducing the immune system based recognition chances, and delivering the gene regulator accurately. Herein, we discuss the mechanism of nanoparticles targeted drug delivery, recent advancement of therapeutic strategies of nanoparticles based carriers for small interfering RNA, and microRNA, and gene augmentation therapies in BC. We also discuss the future prospect and challenges of nanoparticle-based therapies for BC.
Insights
Nanoparticles offer a promising solution for breast cancer (BC) gene therapy, overcoming limitations of conventional treatments. These nanocarriers enhance drug delivery, improving bioavailability and targeting specific BC genes for better therapeutic outcomes.
Area of Science:
- Oncology
- Nanomedicine
- Gene Therapy
Background:
- Breast cancer (BC) remains a leading cause of female mortality, with conventional treatments facing challenges like low bioavailability, poor cellular uptake, resistance, and toxicity.
- Gene therapy for BC using free nucleic acids is hindered by poor cell uptake and instability.
- Nanomedicine offers a promising avenue to overcome these limitations through targeted drug and gene delivery.
Purpose of the Study:
- To review the mechanisms of nanoparticle-mediated targeted drug delivery for breast cancer.
- To discuss recent advancements in nanoparticle-based therapeutic strategies for BC gene therapy, including small interfering RNA (siRNA), microRNA (miRNA), and gene augmentation.
- To explore the future prospects and challenges of nanoparticle-based therapies in breast cancer treatment.
Main Methods:
- Review of nanoparticle-based drug delivery mechanisms.
- Analysis of recent advancements in nanoparticle carriers for gene regulatory agents (siRNA, miRNA) and gene augmentation.
- Discussion of therapeutic strategies and clinical implications.
Main Results:
- Nanoparticles can significantly improve circulation time, bioavailability, and targeted delivery of therapeutic agents for BC.
- Nanocarriers enhance cellular uptake and reduce immune recognition, crucial for effective gene therapy.
- Nanoparticle-based strategies show potential in overcoming resistance and reducing toxicity associated with conventional BC treatments.
Conclusions:
- Nanoparticle-based gene therapy represents a significant advancement in overcoming the limitations of traditional breast cancer treatments.
- Further research and development in nanoparticle design and application are crucial for realizing the full therapeutic potential in BC.
- Nanomedicine holds promise for more effective and safer breast cancer treatment strategies through targeted gene delivery.
Related Concept Videos
Microorganisms in Medicine and Therapeutics
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer
Gene Therapy

